NASDAQ:STSS

Sharps Technology (STSS) Stock Price, News & Analysis

$0.29
0.00 (0.00%)
(As of 04/26/2024 ET)
Today's Range
$0.29
$0.30
50-Day Range
$0.29
$0.39
52-Week Range
$0.27
$1.58
Volume
14,955 shs
Average Volume
186,801 shs
Market Capitalization
$4.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
STSS stock logo

About Sharps Technology Stock (NASDAQ:STSS)

Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

STSS Stock Price History

STSS Stock News Headlines

Move Your Money Before May 1
Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens?
Sonja Sharp
Move Your Money Before May 1
Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens?
Sharp Debuts the First Roku-Powered OLED TVs
Sharps Technology Inc STSS
See More Headlines
Receive STSS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sharps Technology and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/29/2024
Today
4/26/2024
Next Earnings (Estimated)
7/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:STSS
Fax
N/A
Employees
57
Year Founded
N/A

Profitability

Net Income
$-9,840,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.52 per share

Miscellaneous

Free Float
13,461,000
Market Cap
$4.47 million
Optionable
Not Optionable
Beta
1.03
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

STSS Stock Analysis - Frequently Asked Questions

Should I buy or sell Sharps Technology stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sharps Technology in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" STSS shares.
View STSS analyst ratings
or view top-rated stocks.

How have STSS shares performed in 2024?

Sharps Technology's stock was trading at $0.4159 at the beginning of the year. Since then, STSS shares have decreased by 31.4% and is now trading at $0.2851.
View the best growth stocks for 2024 here
.

Are investors shorting Sharps Technology?

Sharps Technology saw a increase in short interest in April. As of April 15th, there was short interest totaling 352,700 shares, an increase of 52.9% from the March 31st total of 230,600 shares. Based on an average daily trading volume, of 180,500 shares, the days-to-cover ratio is presently 2.0 days. Currently, 2.5% of the shares of the company are sold short.
View Sharps Technology's Short Interest
.

When is Sharps Technology's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, July 5th 2024.
View our STSS earnings forecast
.

How were Sharps Technology's earnings last quarter?

Sharps Technology, Inc. (NASDAQ:STSS) posted its earnings results on Friday, March, 29th. The company reported ($0.16) EPS for the quarter.

When did Sharps Technology IPO?

Sharps Technology (STSS) raised $16 million in an initial public offering on Thursday, April 14th 2022. The company issued 3,750,000 shares at $4.25 per share.

How do I buy shares of Sharps Technology?

Shares of STSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:STSS) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners